Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pathologic Complete Response × Colonoscopy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 59 Colonic Neoplasms 20 Colonic Polyps 12 Adenoma 10 Pain 4 Neoplasms 4 Disease 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Gastrointestinal Neoplasms 3 Adenomatous Polyps 3 Stomach Neoplasms 2 Polyps 2 Peptic Ulcer 2 Liver Cirrhosis 2 Intestinal Diseases 2 Inflammatory Bowel Diseases 2 Gastritis, Atrophic 2 Digestive System Diseases 2 Colitis, Ulcerative 2 Turcot syndrome 1 Tuberculosis 1 Signs and Symptoms, Digestive 1 Recurrence 1 Rectal Neoplasms 1 Rectal Diseases 1 Predictive Cancer Model 1 Personal Satisfaction 1 Patient Satisfaction 1 Pathologic Complete Response 1 Pancreatitis, Chronic 1

Interventions

Trastuzumab 4 Oxaliplatin 4 Fluorouracil 4 Cyclophosphamide 4 pembrolizumab 3 Radiotherapy 3 Paclitaxel 3 Endoscopy 3 Docetaxel 3 Cytarabine 3 Chemoradiotherapy 3 Carboplatin 3 Capecitabine 3 Surgical Procedures, Operative 2 Standard of Care 2 Observation 2 Magnetic Resonance Imaging 2 Leucovorin 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Epirubicin 2 Drug Therapy 2 Doxorubicin 2 Cisplatin 2 Blood Specimen Collection 2 zanidatamab 1 venetoclax 1 veliparib 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡